Arrivent Biopharma Inc (AVBP)
23.18
-0.52%
Arrivent Biopharma Inc (AVBP) is currently trading at $23.18. This represents a loss of 0.52% from the previous session. With a market capitalization of $0.96B, AVBP is a key component of the Biotechnology sector. Investors looking to trade AVBP should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade AVBP commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Arrivent Biopharma Inc (AVBP) shows a bearish trend. Analysts are watching the 23.79 level closely.
Fundamentals
Mkt Cap0.96B
P/E Ratio0.0000
Volume174,018
Others Watching (By Market Cap)
JBIOJade Bioscience $14.34
+3.31% ANRO
Alto Neuroscien $19.31
-0.05% NMRA
Neumora Therape $3.44
+0.44% LXEO
Lexeo Therapeut $6.92
+3.47%
60-Day Technical Chart
Advanced Charting
Need more indicators for AVBP? Use the world's #1 platform.
Open AVBP on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $23
| Metric |
AVBP -0.52% |
BMNR +12.50% |
HL +0.97% |
CDE +1.21% |
|---|---|---|---|---|
| Price | $23.18 | $21.87 | $23.87 | $25.09 |
| Mkt Cap | $0.96B | $9.95B | $16.00B | $16.11B |
| - | View → | View → | View → |
Latest Headlines
Here's Why We're Watching ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Situation
simplywall.st • Nov 13, 2025
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)
Seeking Alpha • Dec 25, 2025
How (AVBP) Movements Inform Risk Allocation Models
Stock Traders Daily • Feb 18, 2026
ArriVent BioPharma: Its Leading Asset, Furmonertinib, Supports A Cautious Buy
Seeking Alpha • Jan 4, 2026
ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts
Yahoo Finance • Mar 19, 2025
● Gemini Agentic AI Analyst Insight for AVBP
Market Education
- Blackrock Top Stocks Nov 20, 2023
- Money manifesting videos - POS and used by Nutcases Jul 16, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
External Research